ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD
Clinical trial NCT04227938 · TERMINATED
Trial details
- NCT number
- NCT04227938
- Sponsor
- Alpine Immune Sciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-11
- Primary completion
- 2020-05-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.